US Stocks Pre-market Movement | OptimizeRx falls 4% before market open: Q1 revenue down 10% but profit doubles, full-year guidance lowered

```htmlGlonhui May 13｜The digital technology company specializing in healthcare saw its stock fall 4% to $6 in pre-market trading. According to reports, the company released its financial report for Q1 2026 after the close on May 12. The results showed "declining revenue, improved profitability, and robust growth in AI business": Q1 revenue fell by 10% year-on-year to $19.8 million, but GAAP net loss narrowed significantly, and both Non-GAAP net profit and adjusted EBITDA achieved double-digit growth. Meanwhile, the company lowered its full-year revenue guidance but maintained its adjusted EBITDA target.```